These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20740637)

  • 1. Oncomutations as biomarkers of cancer risk.
    Parsons BL; Myers MB; Meng F; Wang Y; McKinzie PB
    Environ Mol Mutagen; 2010; 51(8-9):836-50. PubMed ID: 20740637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-Ras mutant fraction in A/J mouse lung increases as a function of benzo[a]pyrene dose.
    Meng F; Knapp GW; Green T; Ross JA; Parsons BL
    Environ Mol Mutagen; 2010 Mar; 51(2):146-55. PubMed ID: 19658153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACB-PCR quantification of somatic oncomutation.
    Myers MB; McKinzie PB; Wang Y; Meng F; Parsons BL
    Methods Mol Biol; 2014; 1105():345-63. PubMed ID: 24623241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACB-PCR measurement of K-ras codon 12 mutant fractions in livers of Big Blue rats treated with N-hydroxy-2-acetylaminofluorene.
    McKinzie PB; Delongchamp RR; Chen T; Parsons BL
    Mutagenesis; 2006 Nov; 21(6):391-7. PubMed ID: 17012303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver Mutations.
    Myers MB; McKim KL; Wang Y; Banda M; Parsons BL
    Methods Mol Biol; 2020; 2102():395-417. PubMed ID: 31989569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of tumor-associated mutations in the nasal mucosa of rats exposed to varying doses of formaldehyde.
    Meng F; Bermudez E; McKinzie PB; Andersen ME; Clewell HJ; Parsons BL
    Regul Toxicol Pharmacol; 2010; 57(2-3):274-83. PubMed ID: 20347909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying levels of p53 mutation in mouse skin tumors.
    Verkler TL; Couch LH; Howard PC; Parsons BL
    Environ Mol Mutagen; 2005 Jun; 45(5):427-34. PubMed ID: 15662716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hotspot oncomutations: implications for personalized cancer treatment.
    Myers MB; Wang Y; McKim KL; Parsons BL
    Expert Rev Mol Diagn; 2012 Jul; 12(6):603-20. PubMed ID: 22845481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Have environmental mutagens caused oncomutations in people?
    Thilly WG
    Nat Genet; 2003 Jul; 34(3):255-9. PubMed ID: 12833049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Populations of p53 codon 270 CGT to TGT mutant cells in SKH-1 mouse skin tumors induced by simulated solar light.
    Verkler TL; Delongchamp RR; Couch LH; Miller BJ; Warbritton A; Mellick PW; Howard PC; Parsons BL
    Mol Carcinog; 2008 Nov; 47(11):822-34. PubMed ID: 18381587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulated solar light-induced p53 mutagenesis in SKH-1 mouse skin: a dose-response assessment.
    Verkler TL; Delongchamp RR; Miller BJ; Webb PJ; Howard PC; Parsons BL
    Mol Carcinog; 2008 Aug; 47(8):599-607. PubMed ID: 18314877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of basepair substitution mutation at a frequency of 1 x 10(-7) by combining two genotypic selection methods, MutEx enrichment and allele-specific competitive blocker PCR.
    Parsons BL; Heflich RH
    Environ Mol Mutagen; 1998; 32(3):200-11. PubMed ID: 9814434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.